The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression

By Safont María  

Clinical and Translational Oncology, Vol. 13, Iss. 6, 2011-06 ,pp. : 396-400

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer

By Mazzeo F.   Berliere M.   Kerger J.   Squifflet J.   Duck L.   D'Hondt V.   Humblet Y.   Donnez J.   Machiels J.-P.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 163-169

Elsevier

Access to resources Recommend Favorite

Prediction of optimal versus suboptimal cytoreduction of advanced-stage serious ovarian cancer with the use of microarrays

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 203-204

Informa Healthcare

Access to resources Recommend Favorite

Determination of the Necessary Total Protein Substitution Requirements in Patients with Advanced Stage Ovarian Cancer and Ascites, Undergoing Debulking Surgery. Correlation with Plasma Proteins

By Vorgias George   Iavazzo Christos   Mavromatis John   Leontara Joanna   Katsoulis Michael   Kalinoglou Nickolas   Akrivos Thrassivoulos  

Annals of Surgical Oncology, Vol. 14, Iss. 6, 2007-06 ,pp. : 1919-1923

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I/II Study of Dose-Intense Paclitaxel with Cisplatin and Cyclophosphamide as Initial Therapy of Poor-Prognosis Advanced-Stage Epithelial Ovarian Cancer

By Kohn E.C.   Sarosy G.A.   Davis P.   Christian M.   Link C.E.   Ognibene F.P.   Sindelar W.F.   Jacob J.   Steinberg S.M.   Premkumar A.   Reed E.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 181-191

Academic Press

Access to resources Recommend Favorite